The Patent Finder

Curia Buffalo R&D, LLC

8 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
May 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 2, 2026
    The maintenance fee for Glycine TRANSPORTER-1 Inhibitors, Methods of Making Them, and Uses Thereof (US 9,045,445) comes due Dec 2, 2026. Unpaid by Jun 2, 2027, it lapses early.
  • 1 fee due Sep 24, 2027
    The maintenance fee for Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof (US 10,597,401) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

PatentTitleStatus Expires Confidence
US 8,501,7295-HT3 Receptor Modulators, Methods of Making, and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 8,710,0475-HT3 Receptor Modulators, Methods of Making, and Use Thereof
In force (reinstated)
 · Medium confidence
In force (reinstated)Medium confidence
US 8,124,6005-HT3 Receptor Modulators, Methods of Making, and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 9,045,445Glycine TRANSPORTER-1 Inhibitors, Methods of Making Them, and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,226,456Methods and Compositions for Preventing Opioid Abuse
In force
 · High confidence
In forceHigh confidence
US 10,695,342Methods and Compositions for Preventing Opioid Abuse
In force
 · Medium confidence
In forceMedium confidence
US 11,020,386Methods and Compositions for Preventing Opioid Abuse
In force
 · Medium confidence
In forceMedium confidence
US 10,597,401Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 8: 2 lapsed for an unpaid fee · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited